Attempts to use the gene-editing tool CRISPR to develop a treatment for cancer seem safe and feasible in the earliest findings from the first three patients. "So far, so good," scientists say.
NPR visited the only lab in the world known to be trying to use the powerful gene-editing tool CRISPR to modify the DNA in human sperm. If successful, it could be used to prevent genetic disorders.
Victoria Gray, 34, of Forest, Miss., has sickle cell disease. She is the first patient ever to be publicly identified as being involved in a study testing the use of CRISPR for a genetic disease.
Researchers hope these "embryoids" could provide crucial new insights into how to treat infertility and prevent miscarriages, birth defects and many diseases. But they stir ethical concerns.
A Moscow scientist claims he has a safe way of editing genes in human embryos — a method that could protect resulting babies from being infected with HIV. Approval of the experiment seems unlikely.
Analysis of DNA from more than 400,000 people in the U.K. suggests a genetic modification that protects against HIV may actually increase the overall risk of premature death.
This could be a crucial year for the powerful gene-editing technique CRISPR as researchers start testing it in patients to treat diseases such as cancer, blindness and sickle cell disease.
An international group of 18 prominent scientists and bioethicists is calling for countries around the world to impose a moratorium on the creation of babies whose genes have been altered in the lab.